Related Experiment Video
Updated: May 30, 2026

Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber
Published on: May 30, 2016
No-reflow phenomenon: maintaining vascular integrity
1Heart Institute, Good Samaritan Hospital, Keck School of Medicine, University of Southern California, Los Angeles, CA 90017, USA. rkloner@goodsam.org
The no-reflow phenomenon, characterized by microvascular obstruction, hinders myocardial reperfusion after heart attacks. Identifying and treating this condition can improve healing, reduce heart damage, and enhance survival rates.
Area of Science:
- Cardiology
- Vascular Biology
- Pathophysiology
Background:
- The no-reflow phenomenon describes impaired blood flow to the heart muscle after coronary artery occlusion, despite successful opening of the main artery.
- This condition involves microvascular obstruction, potentially exacerbated by reperfusion injury and emboli during interventions.
Purpose of the Study:
- To review the mechanisms, clinical manifestations, and prognostic implications of the no-reflow phenomenon in myocardial infarction.
- To highlight the need for effective therapeutic strategies to address no-reflow.
Main Methods:
- Review of experimental and clinical studies investigating the no-reflow phenomenon.
- Analysis of diagnostic methods including imaging (MRI, echo contrast) and flow markers (TIMI scores, myocardial blush grade).
Main Results:
- No-reflow is associated with microvascular endothelial swelling, emboli, and reperfusion injury, leading to expanded infarcts in animal models.
- In humans, no-reflow predicts adverse outcomes like left ventricular remodeling, heart failure, shock, and reduced survival, independent of infarct size.
Conclusions:
- No-reflow is a critical determinant of poor prognosis after myocardial infarction.
- Therapeutic interventions targeting no-reflow may improve myocardial healing and patient outcomes, reducing long-term mortality.
Related Concept Videos
Vascular Spasm
Autoregulation of Blood Flow
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Regulation of Angiogenesis and Blood Supply
Clot Retraction and Fibrinolysis
Venous Return
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system as it...
Ischemic Stroke ll: Pathophysiology
